PB2588: PREDICTIVE MODEL OF IN-HOSPITAL CASE FATALITY IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA DEVELOPING CORONAVIRUS INFECTION

PB2588: PREDICTIVE MODEL OF IN-HOSPITAL CASE FATALITY IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA DEVELOPING CORONAVIRUS INFECTION

Bibliographic Details
Main Authors:	Yuri Polyakov, Elena Baryakh, Elena Misyurina, Eugenia Zhelnova, Konstantin Yatskov, Marat Mingalimov, Olga Kochneva, Tatiana Chudnova, Diana Ivanova, Tatyana Tolstykh, Maryana Lysenko
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000977044.04740.8b

Similar Items

P1576: NOVEL APPROACHES TO MANAGEMENT OF COVID-19 IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS
by: Tatiana Chudnova, et al.
Published: (2023-08-01)

PB1853: IN-HOSPITAL SURVIVAL OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND CONCOMITANT CORONAVIRUS INFECTION DEPENDING ON VARIOUS CLINICAL FACTORS.
by: E. Baryakh, et al.
Published: (2022-06-01)

PB1870: COVID - 19 IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: HOSPITAL MORALITY PREDICTORS
by: O. Kochneva, et al.
Published: (2022-06-01)

PB2272: THERAPY AND HOSPITAL MORTALITY PREDICTORS IN HEMATOLOGICAL PATIENTS WITH 4 GRADE NEUTROPENIA AND CONCOMITANT CORONAVIRUS INFECTION
by: K. Kaluzskaya, et al.
Published: (2022-06-01)

P1574: ANTINEOPLASTIC THERAPY FOR HEMATOLOGIC MALIGNANCIES DURING COVID-19
by: T. Chudnova, et al.
Published: (2022-06-01)

P1586: IN-HOSPITAL MORTALITY AND POOR PROGNOSIS FACTORS ASSESSMENT IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND COVID-19.
by: D. Ivanova, et al.
Published: (2022-06-01)

P1599: THERAPY AND HOSPITAL MORTALITY PREDICTORS IN PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS AND CONCOMITANT COVID-19 INFECTION
by: Y. Polyakov, et al.
Published: (2022-06-01)

P1612: ACUTE MYELOID LEUKEMIA IN ADULT PATIENTS: FEATURES OF TREATMENT IN CONTEXT OF THE COVID-19 PANDEMIC.
by: T. Tolstykh, et al.
Published: (2022-06-01)

Coronavirus infection after blood stem cell transplantation
by: E. Yu. Grishina, et al.
Published: (2024-01-01)

Treatment experience of coronavirus infection associated with SARS-CoV-2 in patients with acute myeloid leukemia in the older age group
by: L. T. Shimanovskaya, et al.
Published: (2024-01-01)

Prognostic model and risk factors for hospital mortality in patients with diffuse large B-cell lymphoma associated with coronavirus infection: a single-center cohort study
by: Yu. Yu. Polyakov, et al.
Published: (2024-01-01)

Chemotherapy of hematological malignancies in patients with COVID-19
by: T. S. Chudnova, et al.
Published: (2022-04-01)

Treatment of elderly patients with acute myeloid leukemia: personal experience
by: L. T. Shimanovskaya, et al.
Published: (2024-12-01)

Persistence of a new coronavirus infection in a patient with primary central nervous system large B-cell lymphoma with assessment of the humoral immune response against SARS-CoV-2
by: Yu. Yu. Polyakov, et al.
Published: (2024-04-01)

COVID-19 in patients with acute lymphoblastic leukemia
by: T. S. Chudnova, et al.
Published: (2024-09-01)

COVID-19 in patients with acute leukemia: 3 years' experience of pandemic
by: T. S. Chudnova, et al.
Published: (2024-01-01)

Proceedings of the Pirogov Surgical Societies № 2587–2588
by: article Editorial
Published: (2024-10-01)

Sinonasal diffuse large B-cell lymphoma: own clinical observation and literature review
by: M. A. Mingalimov, et al.
Published: (2024-04-01)

Clinical features and treatment strategy for patients with multiple myeloma during the COVID-19 pandemic
by: V. N. Yakimets, et al.
Published: (2024-01-01)

PB2157: AUTOSCT IN PATIENTS WITH MULTIPLE MYELOMA AND DIALYSIS-DEPENDENT NEPHROPATHY
by: Ekaterina Karimova, et al.
Published: (2023-08-01)

Basic therapeutic approaches to the management of hematology/oncology patients with new coronavirus infection (COVID-19)
by: E. N. Misyurina, et al.
Published: (2024-01-01)

PB2184: COURSE OF CORONAVIRUS INFECTION IN ONCOHEMATOLOGICAL PATIENTS IN THE POST-TRANSPLANT PERIOD
by: E. Grishina, et al.
Published: (2022-06-01)

Chronic lymphocytic leukemia in combination with COVID-19: clinical features and unfavorable prognosis factors
by: O. L. Kochneva, et al.
Published: (2024-01-01)

Treatment features of adult patients with acute myeloid leukemia during the COVID-19 pandemic
by: D. E. Gagloeva, et al.
Published: (2024-01-01)

PB2286: INFLUENCE OF ANTI-CD20 MONOCLONAL ANTIBODY THERAPY ON THE OUTCOME OF CORONAVIRUS INFECTION COVID-19 IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES
by: E. Zotina, et al.
Published: (2022-06-01)

Personalized genotype-directed antitumor therapy for newly diagnosed diffuse large B-cell lymphoma: efficacy and toxicity of the R-CHOP-X protocol in a single-center, non-randomized, prospective clinical trial (first results)
by: M. A. Mingalimov, et al.
Published: (2024-12-01)

Treatment efficiency in patients with acute myeloid leukemia from 2019 to 2023 according to the Moscow Cancer Registry
by: T. N. Tolstykh, et al.
Published: (2024-09-01)

Nivolumab-containing therapy in patients with newly diagnosed classical Hodgkin lymphoma: own clinical observations and literature review
by: D. D. Ivanova, et al.
Published: (2024-12-01)

P912: COVID19 SEVERITY AND THERAPEUTIC OPTIONS IN PATIENTS WITH MULTIPLE MYELOMA
by: E. Karimova, et al.
Published: (2022-06-01)

P363: TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA DURING COVID-19
by: E. Paramonova, et al.
Published: (2022-06-01)

Burkitt’s lymphoma and pregnancy. Advantages of today’s medicine
by: T.S. Kotomina, et al.
Published: (2020-09-01)

PB2683: MODERN DIAGNOSTIC CAPABILITIES OF THE OPHTHALMOLOGICAL STATUS OF PATIENTS WITH ONCO-HEMATOLOGICAL DISEASES.
by: Yusef N Yusef, et al.
Published: (2023-08-01)

Are we ready for the new fatal Coronavirus: scenario of Pakistan?
by: Tauseef Ahmad, et al.
Published: (2020-03-01)

P1571: PREVENTION OF COVID19 IN PATIENTS WITH HEMOBLASTOSIS. OWN CLINICAL EXPERIENCE
by: Ekaterina Grishina, et al.
Published: (2023-08-01)

Identification of Histopathological Biomarkers in Fatal Cases of Coronavirus Disease: A Study on Lung Tissue
by: Ioana-Andreea Gheban-Roșca, et al.
Published: (2023-06-01)

Lipopolysaccharide and ARDS caused by new coronavirus infection: hypotheses and facts
by: I. A. Yatskov, et al.
Published: (2022-03-01)

Clinical and biochemical features of some intravenous iron complexes
by: S. Yu. Abashin, et al.
Published: (2014-07-01)

Clinical and biochemical features of some intravenous iron complexes
by: S. Yu. Abashin, et al.
Published: (2014-07-01)

A clinical case of a new coronavirus infection (COVID-19) with fatal outcome in a patient with tuberous sclerosis
by: Olga G. Kvasova, et al.
Published: (2024-05-01)

Correction: Martínez-Murcia et al. SARS-CoV-2 Variants Identification; A Fast and Affordable Strategy Based on Partial S-Gene Targeted PCR Sequencing. <i>Viruses</i> 2022, <i>14</i>, 2588
by: Antonio Martínez-Murcia, et al.
Published: (2023-03-01)